The treatment of ocular inflammation with medrysone.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D000368:Aged; D003320:Corneal Ulcer / Q000188:drug therapy; D003348:Cortisone / Q000009:adverse effects; D005128:Eye Diseases / Q000188:drug therapy*; D005260:Female; D005901:Glaucoma / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D007249:Inflammation; D007429:Intraocular Pressure / Q000187:drug effects; D007500:Iritis / Q000188:drug therapy / Q000209:etiology; D007634:Keratitis / Q000188:drug therapy; D007635:Keratitis, Dendritic / Q000188:drug therapy; D007637:Keratoconjunctivitis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D013256:Steroids / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D005938:Glucocorticoids; D013256:Steroids; D003348:Cortisone